An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma
Authors
Keywords
-
Journal
Nature Communications
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-11-30
DOI
10.1038/s41467-018-07402-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity
- (2018) Naoto Fujiwara et al. GUT
- CCRK is a novel signalling hub exploitable in cancer immunotherapy
- (2018) Myth T. Mok et al. PHARMACOLOGY & THERAPEUTICS
- Downregulation of CPT2 promotes tumorigenesis and chemoresistance to cisplatin in hepatocellular carcinoma
- (2018) Meihua Lin et al. OncoTargets and Therapy
- High BMI in late adolescence predicts future severe liver disease and hepatocellular carcinoma: a national, population-based cohort study in 1.2 million men
- (2017) Hannes Hagström et al. GUT
- Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma
- (2017) Alexander Gerbes et al. GUT
- Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy
- (2017) Jingying Zhou et al. GUT
- CDK20 inhibition and immune checkpoint blockade: bringing cancer biology and tumour immunology together to develop novel treatment options for HCC
- (2017) Tim F Greten et al. GUT
- Inhibition of the sterol regulatory element-binding protein pathway suppresses hepatocellular carcinoma by repressing inflammation in mice
- (2017) Na Li et al. HEPATOLOGY
- Tumor regulation of the tissue environment in the liver
- (2017) Tobias Eggert et al. PHARMACOLOGY & THERAPEUTICS
- NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis
- (2016) Chi Ma et al. NATURE
- Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation
- (2016) Thomas Welte et al. NATURE CELL BIOLOGY
- Local and transient gene expression primes the liver to resist cancer metastasis
- (2016) T. J. Goodwin et al. Science Translational Medicine
- Histone Deacetylase HDAC8 Promotes Insulin Resistance and -Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma
- (2015) Y. Tian et al. CANCER RESEARCH
- Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma
- (2015) Manal M. Hassan et al. GASTROENTEROLOGY
- A CCRK-EZH2 epigenetic circuitry drives hepatocarcinogenesis and associates with tumor recurrence and poor survival of patients
- (2015) Hai Feng et al. JOURNAL OF HEPATOLOGY
- Liver Damage, Inflammation, and Enhanced Tumorigenesis after Persistent mTORC1 Inhibition
- (2014) Atsushi Umemura et al. Cell Metabolism
- Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis
- (2014) Wen-Lung Ma et al. ENDOCRINE-RELATED CANCER
- The driving circuit of HBx and androgen receptor in HBV-related hepatocarcinogenesis
- (2014) Sheng-Han Wang et al. GUT
- Cell cycle-related kinase mediates viral-host signalling to promote hepatitis B virus-associated hepatocarcinogenesis
- (2014) Zhuo Yu et al. GUT
- 4EBP1/eIF4E and p70S6K/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N-Ras proto-oncogenes in mice
- (2014) Chunmei Wang et al. HEPATOLOGY
- Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer
- (2014) Krasimira Aleksandrova et al. HEPATOLOGY
- SREBP-1 Has a Prognostic Role and Contributes to Invasion and Metastasis in Human Hepatocellular Carcinoma
- (2014) Chao Li et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults
- (2014) Krishnan Bhaskaran et al. LANCET
- NCOA5 Haploinsufficiency Results in Glucose Intolerance and Subsequent Hepatocellular Carcinoma
- (2013) Shenglan Gao et al. CANCER CELL
- Identification of Liver Cancer Progenitors Whose Malignant Progression Depends on Autocrine IL-6 Signaling
- (2013) Guobin He et al. CELL
- The mTOR pathway in hepatic malignancies
- (2013) Mamatha Bhat et al. HEPATOLOGY
- Simple piggyBac transposon-based mammalian cell expression system for inducible protein production
- (2013) Z. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
- (2013) Ophir Shalem et al. SCIENCE
- Epigenetic regulation of hepatocellular carcinoma in non-alcoholic fatty liver disease
- (2013) Yuan Tian et al. SEMINARS IN CANCER BIOLOGY
- Obesity Promotes Liver Carcinogenesis via Mcl-1 Stabilization Independent of IL-6Rα Signaling
- (2013) Sabine Gruber et al. Cell Reports
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- Connecting mTORC1 signaling to SREBP-1 activation
- (2012) Inan Bakan et al. CURRENT OPINION IN LIPIDOLOGY
- Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
- (2012) Hashem B. El-Serag GASTROENTEROLOGY
- Obesity and hepatocellular carcinoma: targeting obesity-related inflammation for chemoprevention of liver carcinogenesis
- (2012) Masahito Shimizu et al. Seminars in Immunopathology
- Coactivation of AKT and -Catenin in Mice Rapidly Induces Formation of Lipogenic Liver Tumors
- (2011) J. K. Stauffer et al. CANCER RESEARCH
- An HNF4α-miRNA Inflammatory Feedback Circuit Regulates Hepatocellular Oncogenesis
- (2011) Maria Hatziapostolou et al. CELL
- Cell cycle–related kinase is a direct androgen receptor–regulated gene that drives β-catenin/T cell factor–dependent hepatocarcinogenesis
- (2011) Hai Feng et al. JOURNAL OF CLINICAL INVESTIGATION
- 4E-BP1 Is a Key Effector of the Oncogenic Activation of the AKT and ERK Signaling Pathways that Integrates Their Function in Tumors
- (2010) Qing-Bai She et al. CANCER CELL
- Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
- (2010) Eek Joong Park et al. CELL
- NF-κB and STAT3 – key players in liver inflammation and cancer
- (2010) Guobin He et al. CELL RESEARCH
- Targeting Eukaryotic Translation Initiation Factor 4E (eIF4E) in Cancer
- (2010) A. C. Hsieh et al. CLINICAL CANCER RESEARCH
- Increased Lipogenesis, Induced by AKT-mTORC1-RPS6 Signaling, Promotes Development of Human Hepatocellular Carcinoma
- (2010) Diego F. Calvisi et al. GASTROENTEROLOGY
- Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection
- (2010) Brad Q. Starley et al. HEPATOLOGY
- High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis
- (2010) Rohit Kohli et al. HEPATOLOGY
- Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings
- (2010) Elizabeth M. Brunt et al. HEPATOLOGY
- Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1
- (2010) Katrin Düvel et al. MOLECULAR CELL
- mTOR: from growth signal integration to cancer, diabetes and ageing
- (2010) Roberto Zoncu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A complex interplay between Akt, TSC2 and the two mTOR complexes: Figure 1
- (2009) Jingxiang Huang et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications
- (2009) Elisa Fabbrini et al. HEPATOLOGY
- Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis
- (2008) Anna Wieckowska et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The High-Mobility Group A1a/Signal Transducer and Activator of Transcription-3 Axis: An Achilles Heel for Hematopoietic Malignancies?
- (2008) J. Hillion et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More